Cargando…
p27(KIP1) is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome
Cell cycle progression is regulated by the combined action of cyclins, cyclin-dependent kinases (CDKs), and CDK-inhibitors (CDKi), which are negative cell cycle regulators. p27(KIP1) is a CDKi key in cell cycle regulation, whose degradation is required for G1/S transition. In spite of the absence of...
Autores principales: | Sáez, Al, Sánchez, E, Sánchez-Beato, M, Cruz, M A, Chacón, I, Muñoz, E, Camacho, F I, Martínez-Montero, J C, Mollejo, M, Garcia, J F, Piris, M A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363083/ https://www.ncbi.nlm.nih.gov/pubmed/10424746 http://dx.doi.org/10.1038/sj.bjc.6690539 |
Ejemplares similares
-
Prognostic role of p27(Kip1) and apoptosis in human breast cancer
por: Wu, J, et al.
Publicado: (1999) -
Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
por: Kamai, T, et al.
Publicado: (2001) -
Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
por: Kuczyk, M, et al.
Publicado: (1999) -
DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27(Kip1), apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas
por: Saegusa, M, et al.
Publicado: (1999) -
MicroRNA signatures in B-cell lymphomas
por: Di Lisio, L, et al.
Publicado: (2012)